Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Third Avenue Management is an investment advisory firm headquartered in New York City, founded in 1986 by the legendary value investor Martin J. Whitman. The firm is widely recognized for its fundamental, bottom-up 'safe-and-cheap' investment philosophy, which emphasizes companies with strong balance sheets and undervalued securities. While the firm may invest in healthcare and biotechnology stocks as part of its diversified portfolios, it is a financial services entity rather than a life sciences or drug development company. Third Avenue manages a suite of mutual funds and institutional accounts, including strategies focused on value equities, real estate, and small-cap stocks. Since 2002, the firm has operated as a majority-owned subsidiary of Affiliated Managers Group (AMG). It does not maintain a clinical pipeline, proprietary therapeutic modalities, or research and development facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Third Avenue Management.